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Abstract 
The kinetics of passive transport of ketoprofen and metformin, as model substances for high and low 
permeability, respectively, across the artificial membrane under the influence of the pH of donor solution 
was investigated. There was an upward trend in the apparent permeation coefficient (Papp) of ketoprofen 
with the decrease in pH to a value close to pKa. At the pH value below pKa the permeation coefficient had 
lower value, due to the higher retention of ketoprofen in the artificial membrane. Metformin is a low 
permeable compound, and the highest permeation values were recorded at pH 7.4. Two dissociation 
constants determine that metformin at physiological pH exists as a hydrophilic cationic molecule, i.e. 
predominantly in ionized form. At pH values below 2.8, metformin mainly exists in diprotonated form, and 
it was, thus, very poorly permeable. The highest retention, i.e. affinity of both ketoprofen and metformin 
to the membrane, was at the lowest pH values, which is explained by different mechanisms. At higher pH 
values of donor compartment the substances showed significantly less affinity to the membrane. The 
obtained values of apparent permeation coefficients at studied pH values showed good correlation with 
the obtained experimental values by other in vitro methods. 
©2021 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative Commons 
Attribution license (http://creativecommons.org/licenses/by/4.0/). 
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Introduction 
The oral route is the most preferred route of drug administration. It is considered safe, effective, and 
readily available, with minimal discomfort to the patient compared to other routes [1]. The absorption of 
orally administered drugs is a function of its dissolution, solubility and permeability of the substance along 
the length of the gastrointestinal tract (GIT) [2]. The absorption of active substances varies depending on 
the pH along the gastrointestinal tract [3]. In general, the absorption of active substances mainly takes 
place in the small intestine, i.e. in the jejunum which has the largest absorption surface [4]. 
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The Biopharmaceutical Classification System (BCS) categorizes drugs into four classes according to their 
water solubility and permeability across intestinal membrane. Based on the available data on low solubility 
and high permeability of ketoprofen, it belongs to class II (BCS II) [5], while metformin as a highly soluble 
and low permeable substance belongs to BSC class III [6].  
Ketoprofen is a non-steroidal anti-inflammatory analgesic. Within the pH of the gastrointestinal tract, 
ketoprofen is an ionized substance (weak acid). The pKa value of ketoprofen is approximately 4.45 at 25 °C 
[7]. 
Metformin is often described as an insulin stabilizer because, due to its positive effects on insulin 
acceptor and tyrosine kinase activity, it leads to a decrease in plasma insulin levels and insulin resistance 
[8]. Metformin has two different values of the dissociation constant, namely pKa 2.8 and 11.5, and as a 
result of which at physiological pH it exists as a hydrophilic cationic molecule. At pH values below 2.8, it 
mainly exists in diprotonated form, and thus difficult to permeate. At pH values higher than 11.5 it is found 
in non-ionized form which is the most favorable form for passive transport across membranes [9], however 
this pH is not found physiologically. 
Models for determining permeability are used in the early stages of drug discovery and development 
and are a major strategy to prevent drug rejections due to poor pharmacokinetics in the later, more 
expensive phases of clinical trials [10]. The most reliable way to determine the permeation of active 
substances is in vivo testing of human intestinal perfusion. However, due to simpler, faster and much less 
expensive performance compared to the in vivo tests, in situ, ex vivo and in vitro models are mainly used 
for permeation assessment [11].  
In vitro methods are the most commonly used alternative for testing the permeation of active 
substances [12]. Depending on the biopharmaceutical class of the active substance, they may have a good 
correlation with the in vivo results [13]. Most active substances are absorbed by passive transport, so the 
application of in vitro methods using artificial membranes that mimic passive transport is considered an 
effective and reproducible method for assessing permeability [12], especially in screening stages of drug 
discovery.  
Absorption, distribution, metabolism, excretion and toxicity are greatly influenced by the charge of the 
active substances at different pH conditions. Consideration of pH values in relation to other molecular 
properties is of great importance and has the potential to be used to further improve the efficacy of the 
application of active substances [14]. The method of permeation testing on artificial membranes, which 
could reliably predict the passive transport of the active substance as a function of pH, would significantly 
facilitate the characterization of new candidate substances in the initial stages of drug development. 
In this work, the kinetics of passive transport of ketoprofen (BCS II) and metformin (BCS III), as model 
substances for high and low permeability, respectively, across the artificial membrane under the influence 
of the pH value of the donor solution was investigated. The results were compared with the available 
literature data obtained by different permeation methods of these two substances. 
Experimental  
Materials 
Deionized water was obtained on Arium 611, Sartorius (Sartorius Lab Instruments GmbH & Co. KG, 
Göttingen, Germany). The materials used in this experimental work include: disodium hydrogen phosphate 
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dihydrate (Kemika, Zagreb, Croatia), cholesterol (Sarajevolijek, Sarajevo, Bosnia and Herzegovina), 
potassium dihydrogen phosphate (Semikem, Sarajevo, Bosnia and Herzegovina), disodium hydrogen 
phosphate (Kemika, Zagreb, Croatia), ketoprofen, working standard (LEK, Slovenia), metformin 
hydrochloride, reference standard (Merck, Darmstadt, Germany), sodium chloride (Merck, Darmstadt, 
Germany), n-octanol (Semikem, Sarajevo, Bosnia and Herzegovina), hydrochloric acid (Lach-ner, sro 
Neratovice, Czech Republic), 85 % phosphoric acid (Mallinckrodt Baker BV, Deventer, The Netherlands). Egg 
lecithin (Lipoid® E80) was a kind gift from Lipoid GmbH, Ludwigshafen, Germany. 
Methods 
In the experimental work, the Instructions for use of the apparatus absorption simulator Sartorius 
Model SM 16750 (Sartorius Membranfilter GmbH, Germany) and the method of the authors Corti et al. 
[1,15] and our study group [16] were used. Cellulose nitrate filter (mixed cellulose ester), pore size 0.45 µm 
(Sartorius AG, Göttingen, Germany) was impregnated with 2 mL solution of 2.10 % cholesterol and 1.70 % 
egg lecithin (Lipoid® E 80) in n-octanol for 10 minutes. The excess impregnation solution was removed by 
pressing a filter located between the two absorbent papers. The mass of the filter before and after 
impregnation was determined using an analytical balance (AG 400, Metler Toledo GmbH, Switzerland) from 
which the percentage of impregnation solution retained on the filter was calculated as filter mass increase. 
The filter prepared in this way was placed in a diffusion cell of absorption simulator connected to the 
donor and acceptor compartments. The donor compartment contained a solution of 500 µmol L-1 of active 
substance (ketoprofen or metformin) in 100 mL of phosphate buffer of different pH values. The pH values 
of the buffer in the donor compartment were: 7.4, 6.8, 4.5 and 3.0 or 2.0 for ketoprofen or metformin, 
respectively. Phosphate buffer of pH 7.4 was present in the acceptor compartment in all experiments. The 
temperature in both compartments was measured and maintained at 37 ± 0.5 °C. Under the action of the 
peristaltic pump, the contents of the donor and acceptor compartment were constantly circulating through 
the diffusion cell on both sides of the membrane (Figure 1).  
At 30, 60, 90 and 120 minutes, sampling was performed from the acceptor compartment and the 
concentration of active substances (ketoprofen or metformin) was determined spectrophotometrically. 
Spectrophotometric measurements were performed on UV-VIS spectrophotometer UV-1601 (Shimadzu, 
Kyoto, Japan). The method was validated prior to the permeation experiments according to ICH guideline 
Q2-R1 [17].  
After reading the results on the spectrophotometer, the samples were returned to the acceptor 
compartment. At the end (120 minutes), the samples were also taken from donor compartment, and 
concentration of ketoprofen or metformin was determined spectrophotometrically. This data was used to 
calculate the recovery value (R). Each experiment was performed in triplicate. 
From the samples taken from the acceptor compartment, the apparent permeability coefficients of 







 , (1) 
where Papp - apparent permeation coefficient, cm s
-1; dQ/dt - mass of the substance that passed through 
the membrane per unit time, mg s-1; A - effective surface of the artificial membrane through which the 
permeation was examined, cm2; C0 - initial concentration of active substance in donor solution, mg mL
-1. 
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Figure 1. Absorption simulator Sartorius Model 
SM 16750 
Recovery of ketoprofen and metformin (as a percentage of the substance not retained in the 
membrane) was determined according to Equation 2: 
, ,
,0
%  x 100a end a d end d
d d




 , (2) 
where Ca, end and Cd, end - concentration of test substance measured at the end of the experiment in acceptor 
and donor solution, mg mL
-1
; Cd,0 - initial concentration of test substance in donor solution, mg mL
-1
; Va and 
Vd - volumes of acceptor and donor solution, mL. 
Results and discussion 
Permeations of ketoprofen and metformin were monitored in this experimental work at different pH 
values of the donor compartment, while the pH of the acceptor compartment was 7.4 in all cases. In this 
way, it was possible to examine the permeation of the substances from the donor compartment at 
different pH values, which simulated GIT conditions across an artificial membrane embedded in a diffusion 
cell in the acceptor compartment that reflected the pH conditions of the systemic circulation. 
A membrane filter with pore size of 0.45 µm was used in this work. As we mentioned in the earlier work 
[16] the pore size of the membrane filter does not affect the permeability of active substances across the 
artificial membrane, since in Corti et al. [1] there was no clear causal relationship between Papp and pore 
sizes established.  
According to the Instructions for use of the apparatus (Sartorius Model SM 16750), the increase in filter 
weight after impregnation should be 100 ± 5 %. The mean value of the percentage of impregnation of the 
membrane, i.e. the average increase in filter mass was 158.67 ± 5.59 %. These values are similar to the 
values of experimental studies conducted by Corti et al. [1] and our study group [16]. According to both 
studies, the structure of a membrane filter that was not originally intended for use in this experiment is 
responsible for the larger increase in filter mass after impregnation. 
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Permeation of ketoprofen dependent on the pH of the donor solution 
The ketoprofen permeation profiles' parameters at different pH of the donor compartment are 
presented in Table 1 and Figure 2. 
Table 1. Mean values (n = 3) of the apparent permeation coefficients (Papp) of ketoprofen, the 
recovery of the substance not retained by the membrane (R) and percentage of calculated 
(non)ionized species (HA/A
-
) at different pH values of donor compartment. 




) ± SD R(%) ± SD HA/A
-
 (%) 
7.4 6.95 ± 0.51 97.95 ± 2.42 0.11 / 99.89 
6.8 16.8 ± 1.10 87.83 ± 2.77 0.44 / 99.56 
4.5 41.6 ± 1.67 83.52 ± 1.68 47.17 / 52.83 
3.0 12.9 ± 0.28 51.91 ± 1.79 96.61 / 3.39 
 
 
Figure 2. Overall permeated amount of ketoprofen through the artificial membrane at different pH values of 
donor compartment. 
Large values of the apparent permeation coefficients confirm that it is a highly permeable substance. 
The low standard deviation of the apparent permeation coefficients shows good reproducibility of the 
method for highly permeable substances. The recovery values indicate whether ketoprofen was retained in 
the membrane, and this retention varied significantly depending on the pH value. 
In general, ionized substances are better soluble, and non-ionized ones pass through the cell membrane 
better. The calculated percentage of non-ionized ketoprofen decreased from 96.61 % for pH = 3.0 to 0.11 
% at pH = 7.4 (Table 1). Ketoprofen is a weak acid and its maximum permeation is expected in areas where 
the pH value is close to the pKa of the substance, which in the case of ketoprofen is 4.45, where there is 
47.17 % non-ionized ketoprofen. These obtained calculated values of the proportions of ionized and non-
ionized species explain the values of the apparent permeation coefficients and recovery factors at 
individual pH, discussed below. 
It can be seen from Figure 2 that the equilibrium permeation concentrations were not established at 
any pH during the 120-minute test period. 
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In general the values of Papp in all pH media were high (Table 1). Such results indicate high permeability 
of ketoprofen, which is in line with the literature data showing that ketoprofen belongs to BCS class II. 
The recovery value increased with increasing pH (Table 1), and for pH = 7.4 the recovery value was 
97.95 %. Such a high value indicates that a very small percentage of the substance was retained by the 
membrane. The recovery value decreased with decreasing pH, and the lowest percentage of the recovered 
substance was measured at pH = 3 and it was R = 51.93 %. In case of weak acids, such as ketoprofen, the 
proportion of non-ionized substance is increased at pH values below pKa, i.e. pH of 3.0 in this case. The 
increased portion of non-ionized substance makes this substance more lipophilic and thus has a higher 
affinity for the lipophilic membrane.  
When analysing the obtained values of apparent permeation coefficients from Table 1, it can be noticed 
that unlike recovery values, Papp did not have a linear growth with pH values. The lowest mean value of the 




) was at pH = 7.4. Regardless of the fact 
that the recovery value at this pH shows the highest percentage, and Papp is the lowest, such results are 
consistent with the results obtained in the original method. In the original Papp method, the value for 
ketoprofen at pH = 7.4 was 4.27 ± 0.08 × 10-5 cm s-1 and R = 99.1 % [15]. The apparent permeation 
coefficient showed the highest values at pH = 4.5, which was to be expected given that the maximum 
permeation of ketoprofen is expected at pH values that are closest to the pKa value of the substance, 
which for ketoprofen has a value of 4.45. This is due to the fact that at this pH value there is a higher ratio 
of non-ionized substance, which permeates, compared to higher pH values, and, on the other hand, there 
is less retention in the membrane compared to lower pH value that is bellow pKa value, probably due to 
the larger portion of the ionized form. The apparent permeation coefficient was 41.6±1.67 × 10-5 cm s-1. 
This result confirmed the high permeability of ketoprofen, and is in line with the fact that ketoprofen is a 
weak acid, the absorption of which is expected at a weakly acidic to neutral pH values. Measurement with 





. These values correlate with all the above facts related to the permeation properties of ketoprofen. 
At pH = 3.0, the mean Papp value obtained was 12.9±0.28 × 10
-5 cm s-1. These results were expected, and it 
is assumed that if there was no increased affinity of the substance and the membrane, it would be even 
higher at this pH value.  
Table 2. Experimentally obtained apparent permeation coefficients of ketoprofen (cm s
-1
) at different pH values 
and literature data obtained by other methods. 
pH Papp ± SD (×10
-5) Fa %a Papp ± SD (×10
-5)b Papp ± SD (×10
-5)c Peff ± SD (×10
-5)d log De 
3.0 12.9 ± 0.28 / / / / / 
4.5 41.6 ± 1.67 99.9 6.02 ± 2.4** / / 1.8** 
6.8 16.8 ± 1.1 100 1.86 ± 1.5*** 26.0 ± 13.4*** 29.2 ± 0.7*** 0.8 
7.4 6.95 ± 0.5 100 0.24 ± 0.7 15.8 ± .24 23.5±0.7 0.1 
a
Values of simulated Fa (dose fraction absorbed in humans) [18]; 
b
BML-PAMPA (biomimetic lipid parallel artificial membrane 
permeability assay) Papp values [19]; 
c
Papp values obtained by Ussing chambers' model [20]; 
d
SPIP Peff (effective permeation 
coefficient) values [20]; 
e
Log D (distribution coefficient) values [20,21]; * Values at pH = 2; **Values at pH = 5.5; ***Values 
at pH = 6.5 
Numerous methods for testing absorption/permeation have been described in the literature. Table 2 
shows the literature accounts of experimentally obtained values of other methods for testing the 
permeation of ketoprofen at certain pH values, as well as the literature values of the in silico simulated 
dose fraction absorbed in humans (Fa), and log D. The correlations between the obtained results and these 
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literature data were examined. In general, this type of testing referring to pH dependence is scarce and 
lacking.  
Due to the lack of experimental data on the permeation coefficients of ketoprofen at the exact same pH 
values, the values at approximate pH were taken for certain parameters, as indicated in the Legend of 
Table 2.  
Dose fraction absorbed in humans of ketoprofen is 90 %, and it is mainly absorbed in the small intestine 
[5]. However, due to the lack of pH dependent data on its in vivo absorption, the obtained results cannot 
be compared or correlated. The results were compared with the available results of in silico simulated 
fraction of the dose absorbed in humans at different pH values and gave the correlation factor of R2 = 
0.9239.  
The comparisons of the results of in situ and ex vivo models [20] were possible only at two pH values, 
namely pH = 6.8 and pH = 7.4, so it was not purposeful to calculate the correlation coefficient. However, 
the trend of increasing permeation with decreasing pH of the environment in both cases was evident 
(Table 2). The same trend was present for the BML-PAMPA assay and log D results, even taking into 
consideration that the pH was different near pKa of ketoprofen in the two experiments. 
Comparison of the obtained results with the results of Corti et al. [15] and our earlier results [16] was 
not possible due to the lack of data on apparent permeation coefficients for all pH values. 
Permeation of metformin dependent on the pH of the donor solution 
The metformin permeation profiles' parameters at different pH of the donor compartment are 
presented in Table 3 and Figure 3. 
The pKa value of 11.5 makes metformin a strong base found in non-ionized form in the percentage of 
only 0.008 % at pH 7.4. Given the physicochemical properties of metformin (pKa values, log P) that 
determine its high solubility and poor permeability, metformin will prevail at physiological pH in ionized 
form, which will favor its solubility, but will not favor passive transport. Due to its properties, metformin is 
mainly absorbed in vivo by active transport via number of transporters located in intestinal membranes 
[22]. Otherwise, for drugs belonging to BCS class III, it would be possible to establish an in vivo - in vitro 
correlation if the drug is highly soluble (such as metformin), if it is not subject to the first pass effect and is 
not metabolized (such as metformin) and if it is not transported by carriers. Since it does not meet the 
third criterion, it is not possible to establish an in vitro - in vivo correlation for metformin, but it is possible 
to examine the extent to which passive transport is involved in its permeation and the effects of pH on this 
type of permeation.  
Table 3. Mean values (n = 3) of the apparent permeation coefficients (Papp) of metformin, the 
recovery of the substance not retained by the membrane (R) and percentage of calculated 
(non)ionized species (BH2
2+/BH+/B) at different pH values of donor compartment. 
pH Papp (× 10
-8 cm s-1) ± SD R(%) ± SD BH2
2+/BH+/B (%) 
7.4 29.82 ± 1.095 96.19 ± 4.92 0.0025 / 99.99 / 0.008 
6.8 9.83 ± 0.199 90.00 ± 2.73 0.010 / 99.99 / 0.002 
4.5 9.79 ± 0.234 90.37 ± 3.20 1.96 / 98.04 / 9.8 × 10
-6 
2.0 5.53 ± 0.556 85.31 ± 4.45 86.32 / 13.68 / 4.33 × 10
-9 
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Figure 3. Overall permeated amount of metformin across the artificial membrane at different pH values of donor 
compartment. 
At pH 2.0 (which corresponds to the gastric pH) most of metformin (86.32 %) is in diprotonated form, 
i.e. it is in the form of a double positively charged ion. In the protonated form, positively charged 
metformin at this pH value is present at 13.68 %, while the non-ionized form is represented by only 4.33 × 
10-9 %. These data point to the fact that metformin at the pH value of the stomach is very difficult to 
passively permeate through physiological membranes, which the obtained results confirm. 
Table 3 shows that the Papp value was 5.53 × 10
-8 cm s-1, very low due to the low permeability of the 
substance at pH 2.0. Metformin is at gastric pH, a highly ionized molecule and as such cannot passively 
permeate through physiological membranes. The recovery value was 85.31 %, indicating a higher retention 
of metformin in the artificial membrane than at other pH values of the donor compartment, probably due 
to the affinity of metformin for membrane components made of cellulose nitrate and phospholipids from 
the impregnation solution.  
At pH 4.5, the share of the diprotonated form of metformin is 1.95 %, while the single positively 
charged form dominates (98.04 %). Non-ionized form of the molecule is present in a percentage of 9.8 x 
10-6 %. Although present in extremely low percentage, the non-ionized form of metformin is still 
insufficient for unobstructed passive permeation, and the Papp value was 9.79 ×10
-8 cm/s at this pH. The pH 
value of 4.5 is present at the level of the duodenum from where in vivo metformin absorption will start to 
take place.  
At pH values of 6.8, metformin is found in the non-ionized form in portion of 0.0019 %. Passive 
permeation in this case is more pronounced than at lower pH values. Generally, in vivo metformin 
absorption mainly takes place from GIT regions where the pH value is 6.8. However, in vivo absorption is 
aided by a number of protein carriers and transporters located along the length of the intestinal mucosa 
that facilitate and enable cellular uptake of metformin from the apical to the basolateral membrane of 
enterocytes. Therefore, an in vitro model based exclusively on passive transport could not adequately map 
events at physiological pH 6.8, but only the passive component of membrane transport. Since the non-
ionized content is lower than at pH 7.4, the permeation rate is lower at this pH of the environment. The 
mean Papp value shown in Table 3 was 9.83 ×10
-8 cm s-1.  
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At pH 7.4 metformin is present in the non-ionized form 0.008 %. Although the concentration of the 
uncharged form is extremely low, it is the highest at the studied pH values and as such shows the best 
permeation rate and extent through the artificial membrane. 
The pH value of the donor compartment was the furthest from the lower pKa value for metformin (2.8), 
which favored its existence in non-ionized form, and enabled its passive permeation across the artificial 





. Although this permeation rate is low compared to substances that show good permeability, this is 
the highest value of permeation obtained in this experimental work due to the fact that at these pH values 
the highest percentage of non-ionized form is present compared to other studied pH values. Thus, 
metformin is a low permeable compound whose absorption is more favored by alkaline pH values (Figure 
3). The recovery value of R = 96.19 % (Table 3) indicates that metformin mostly uninterruptedly 
permeated.  
In summary, metformin is highly ionized throughout the length of the GIT, which explains its low 
permeability by passive transport. It also explains the fact that metformin is in BCS class III (high solubility - 
low permeability). Its permeability, as mentioned earlier, is significantly higher in vivo, since it is suggested 
to be absorbed by active transport through supported carriers [22]. 
In Figure 3, it can be seen that as the pH value increases, the slopes of the metformin permeation 
profile increase, so the highest Papp values were observed at pH 7.4. At this pH value, metformin has good 
solubility, low lipophilicity, and the highest concentration of non-ionized substance compared to the other 
studied pH values, thus it more easily permeates into the acceptor compartment with very small 
percentage of retention in the artificial membrane. The log D value for metformin is -1.43, which indicates 
low solubility in lipids, and thus low affinity for the membrane, which is lipid in nature. As can be seen from 
Figure 3, after the initial jump in the concentration of permeated metformin after 30 minutes at pH 2.0, 
almost a plateau is reached, which can be explained in that the saturation of metformin in the membrane 
is reached and diprotonated molecules repel each other impeding further permeation through the 
membrane. This is similar, although less pronounced, at higher pH values. 
The behavior of metformin at pH values of 6.8 and 4.5 corresponding to the small intestine was shown 
to be very similar (Figure 3). Even though low permeation rates were observed at both pH values, 
permeation of metformin at pH 4.5 physiologically present in the duodenum showed a slight, although 
insignificant, advantage. 
In humans, metformin absorption is incomplete and bioavailability shows interindividual variability at 
55 ± 16 %. Absorption ceases 6 - 10 hours after administration, regardless of the amount of metformin 
administered, which is approximately the time of passage of the drug through the stomach and small 
intestine [27]. Human data are lacking in pH dependent transport across the GIT membranes, and thus 
cannot be further discussed. 
Lassoued et al. [23] in their comparative study of permeation of metformin by the Sartorius SM 16750 
absorption simulator model and inverted sac technique showed a good correlation in the determination of 
metformin permeability. 
The results of the study conducted by Song et al. [24] concluded that metformin is transported via 
saturable carriers. The results were not correlated with dynamic diffusion cell model due to the difference 
in the used methods. 
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Table 4. Experimentally obtained apparent permeation coefficients (cm s
-1
) of metformin at different pH 
values and literature data obtained by other methods. 














































2.0 0.055±0.006 / / / / / / / / 
4.5 0.098±0.002
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45.1±10.8 
(duodenum) 





















/ -1.23 5.5 / 
a
Values Papp obtained by inverted sac and Sartorius model [23]; 
b
Values Papp obtained on the same Sartorius model with the 
same experimental conditions with impregnation solution variation [16]; 
c
Values Papp obtained on isolated duodenum, 
jejunum and ileum segments in Caco-2 cell model [24]; 
d
Values log D and Papp obtained by Caco-2 cell model [25]; 
e
Values 
Papp obtained by Caco-2 cell model [26] 
However, in the study conducted by Nicklin et al. using the Caco-2 model it was concluded that 
metformin is transported in the Caco-2 monolayer by passive, unsaturable transport [25]. The 
hydrophilicity and molecular weight of metformin determined the Papp value of 5.5 × 10
-6 cm s-1, which is 
comparable with the results of other hydrophilic high molecular weight compounds tested by the Caco-2 
model [28], but also with the results obtained in this experimental work at the same pH values (Table 4). 
On the other hand, in the Caco-2 cell model study conducted by Proctor et al. [26] the transport and 
absorption of metformin took place via saturable transport mechanisms. The relative contribution of 
transcellular and paracellular transport of metformin at a concentration of 0.05 mM was estimated at 9 % 
and 91 %, respectively [26].  
Log D values at the studied pH were below 0.5 which implies poor permeability of metformin within the 
physiological pH range prevailing at the GIT level, which is in line with the obtained results. However, the 
correlation of the results with the available log D values was very poor (R
2
 = 0.63). 
Conclusions 
Ketoprofen is a highly permeable acid, while metformin is dibasic substance with low permeability. pH 
dependent passive transport through an artificial biomimetic membrane of both substances could be 
explained by their ionization properties at studied pH values of donor compartments. Log D values of 
ketoprofen correlated well, while those of metformin did not. The literature accounts of pH dependent 
permeation/absorption are scarce. However, when considering those available, the results correlated well 
with the other in vitro studies.  
The dynamic diffusion cell model has proven to be an efficient, reproducible and simple method for 
predicting the permeation of ketoprofen. This model examines passive transport across the membrane, 
and for substances that are absorbed by other forms of transport, such as metformin, this method can be 
used to predict only its passive transport component.  
The dynamic diffusion cell model is a good foundation for future research as a valuable resources-saving 
screening tool for the new drug candidates at the beginning stages of their development, as well as for 
known substances permeation elucidation, especially considering its potential for testing at wide range of 
pH conditions, which is very difficult by other methods. 
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